IRIS
VISCIDO, ANGELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.476
EU - Europa 2.495
AS - Asia 1.060
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 2
Totale 8.046
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.460
IE - Irlanda 974
CN - Cina 555
TR - Turchia 375
DE - Germania 329
IT - Italia 287
SE - Svezia 237
UA - Ucraina 215
GB - Regno Unito 161
FI - Finlandia 104
FR - Francia 88
SG - Singapore 87
CZ - Repubblica Ceca 38
BE - Belgio 27
IN - India 14
CA - Canada 13
VN - Vietnam 12
RU - Federazione Russa 11
NL - Olanda 7
JP - Giappone 6
AU - Australia 4
EU - Europa 4
ES - Italia 3
HK - Hong Kong 3
BR - Brasile 2
CH - Svizzera 2
IL - Israele 2
IQ - Iraq 2
LU - Lussemburgo 2
PL - Polonia 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
BM - Bermuda 1
BT - Bhutan 1
CR - Costa Rica 1
EC - Ecuador 1
EE - Estonia 1
GH - Ghana 1
IR - Iran 1
KR - Corea 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 8.046
Salva come PNG Salva come JPEG
Città #
Chandler 979
Dublin 964
Jacksonville 941
Ashburn 344
Izmir 197
Nanjing 158
Boardman 152
San Mateo 151
Lawrence 149
Princeton 149
Wilmington 142
New York 118
Ann Arbor 114
Beijing 86
Dearborn 76
Singapore 64
L'aquila 62
Milan 51
Bremen 50
Woodbridge 42
Brno 37
Des Moines 37
Shenyang 37
Los Angeles 36
Nanchang 36
Seattle 34
Kunming 31
Tianjin 30
Verona 30
Berlin 28
Brussels 27
Norwalk 24
Jinan 23
Munich 23
Shanghai 21
Dallas 18
Zhengzhou 18
Helsinki 17
Jiaxing 17
Hebei 16
Mountain View 13
Changsha 12
Dong Ket 12
L’Aquila 12
Rome 12
Fairfield 11
Hefei 10
Ningbo 10
Fremont 9
Changchun 8
Hangzhou 8
Phoenix 8
Auburn Hills 6
London 6
Pune 6
Reggio Nell'emilia 6
Tappahannock 6
Toronto 6
Cedar Knolls 5
Edinburgh 5
Falls Church 5
Frankfurt am Main 5
Guangzhou 5
Bologna 4
Borgosatollo 4
Florence 4
Lappeenranta 4
San Francisco 4
Amsterdam 3
Haikou 3
Huskvarna 3
Lanzhou 3
Napoli 3
Philadelphia 3
Redmond 3
Stockholm 3
Washington 3
Baotou 2
Cambridge 2
Chicago 2
Cormeilles-en-Parisis 2
Düsseldorf 2
Faenza 2
Fisciano 2
Hong Kong 2
Madrid 2
Melbourne 2
New Delhi 2
Nuremberg 2
Ottawa 2
Padova 2
Paris 2
Perugia 2
Pescara 2
Prata 2
Redwood City 2
Santa Clara 2
Shaoxing 2
São Paulo 2
Taizhou 2
Totale 5.808
Salva come PNG Salva come JPEG
Nome #
Efficacia di un nuovo preparato di olio di pesce sulla recidiva del Morbo di Crohn. Giornale di Gastroenterologia 1996;1:158-162 299
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 127
Subtypes of chronic gastritis in patients with coeliac disease before and after gluten-free diet 110
Association between colonic diverticula and colorectal polyps and cancer 107
Lymphocytic gastritis is present in Celiac Disease and improves after gluten-free diet. 100
Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms 99
Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet 98
Association between colorectal polyps and colonic diverticulosis 97
Histological healing in ulcerative colitis with mesalazine and its prognostic role 93
Colite acuta dopo colonscopia. Giornale di Gastroenterologia 1997; 2: 88-93 82
Survival and causes of death in Italian patients with ulcerative colitis. A GISC nation-wide study. 80
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. 78
In favour of prophylactic treatment for post-operative recurrence in Crohn's disease. 78
Clinical course of Crohn's disease first diagnosed at surgery for acute abdomen. 76
Mesalazine treatment in organotypic culture of celiac patients: Comparative study with gluten free diet 75
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy. 74
Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with Crohn's Disease: a GISC study 72
Italian Group for the Study of the Colon and Rectum: Survival and causes of death in Italian patients with ulcerative colitis. A GISC nationwide study 72
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 71
Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. 70
Current management of severe ulcerative colitis. 70
Prognostic factors for postoperative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC) 69
Nanotechnology in the treatment of inflammatory bowel diseases. 69
Il 5-ASA (ASACOL) previene le recidive post-operatorie del morbo di crohn (MC): risultati dello studio GISC a tre anni di follow-up. 68
Safe use of infliximab for the treatment of fistulizing Crohn’s disease during pregnancy within 3 months of conception. 68
NK activity and antibody-dependent cellular citotoxicity (ADCC) in inflammatory bowel disease(IBD) 67
Prognostic factors for post-operative recurrence of Crohn's disease 67
MRI in Crohn’s disease: assessment of treatment response or relapse 66
Acute colitis following endoscopy: an outbreak of three cases 66
Mucosal healing: Mayo 0 vs 1 after 3 years. 66
Mastocytic enterocolitis: Increase of mast cells in the gastrointestinal tract of patients with chronic diarrhea 66
Acute colitis following colonoscopy 64
A mathematical model to study natural history of crohn’s disease. 64
The prognostic value of histology in ulcerative colitis in clinical remission with mesalazine 64
Recidive stenosanti ricorrenti nel morbo di Crohn. Giornale di Gastroenterologia, 1999, 4: 150-155 64
Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease 63
A new technique of magnetic resonance imaging (MRI) in the management of patients with Crohn's disease. 63
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 63
Quinidine-induced colitis. Report of three cases. 62
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 62
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A double blind randomised clinical trial. AGISC study. 62
Two mesalazine regimens in the prevention of postoperative recurrence of Crohn's disease: A pragmatic double blind randomised controlled trial . Aliment Pharmacol Ther 2003;17:517-523 62
Value of T2-weighted fat suppressed and non suppressed sequences after oral administration of a superparamagnetic contrast agent in the assessmento of Crohn's disease activity 61
5-ASA enemas increase mucosal availability of mesalamine up to splenic flexure. 61
An unusual treatment for a colonic polyp. 60
Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. 60
Recidiva postoperatoria del morbo di Crohn: un modello matematico per lo studio dell'evoluzione delle lesioni. 60
CROHN’S DISEASE ACTIVITY INDEX IS INACCURATE TO DETECT THE POSTOPERATIVE RECURRENVCE IN CROHN’S DISEASE 59
GI distension in severe ulcerative colitis 59
Mucosal concentration of 5-ASA in the distal colon. Comparison between oral and plus topical treatment. 59
L’intestino nei pazienti critici. La barriera mucosa intestinale e le sue alterazioni (prima parte). Giornale di Gastroenterologia 1998; 3: 70-103 59
Gastrointestinal distension in severe ulcerative colitis 58
Metabolic Alterations in Celiac Disease Occurring after Following a Gluten-Free Diet 58
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations 57
Gastrointestinal distension in severe ulcerative colitis (UC). 57
Linfociti circolanti gamma-delta in corso di malattie infiammatorie intestinali. 57
MRI EVALUATION OF CROHN DISEASE OF THE SMALL AND LARGE BOWEL USING NEGATIVE SUPERPARAMAGNETIC CONTRAST AGENT 56
Multiple organ dysfunction complicating severe ulcerative colitis. 56
Colonic mucosal concentration of 5-ASA in ulcerative colitis. 56
Post-operative recurrence of Crohn’s Disease: a study for the development of lesions in treated and untreated patients. 56
Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. 55
Rectal and colonic mesalazine concentration in ulcerative colitis: oral vs. oral plus topical treatment 55
Detection of post-operative recurrence in Crohns disease (CD). 55
Surgery at diagnosis of Crohn’s disease reduces the need for steroids and immunomodulators 54
Multiple organ dysfunction syndrome (MODS) complicating severe ulcerative coliyis (UC) 54
CDAI is inadequate for diagnosis of post-operative recurrence of Crohn’s Disease 54
Detection of post-operative recurrence in Crohns disease (CD). Proceedings of 5th Congress of the European Council for Coloproctology (ECCP), Barcellonas, Spain, June 14-17, 1995. Edited by J. Martì Raguè and J. de Oca Burguete, Barcelona (Spain), Monduzzi Editore, 1995: p.63-66 54
"Crohn's disease activity index" is inaccurate to detect the post-operative recurrence in Crohn's disease. A GISC study. 53
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. 53
Early versus late surgery for ileo-caecal Crohn's disease. 53
Unmet medical needs in the management of ulcerative colitis: Results of an Italian delphi consensus 53
Duodenal Intraepithelial CD8+ Lymphocytosis in Patients with Functional Dyspepsia. 52
Magnetic resonance enterography (MRE) and ultrasonography (US) in the study of the small bowel in Crohn's disease: state of the art and review of the literature 52
Is fecal calprotectin an accurate marker in the management of Crohn's disease? 52
Diarrea Cronica In: Disturbi cronici intestinali, E.Corazziari Ed., Milano, Messaggi, 2003:127-135 51
Postoperative recurrence in Crohn's disease. 50
Hydro-CT in patients with gastric cancer: Preoperative radiologic staging 50
Il CDAI è inadeguato per la diagnosi della recidiva post-operatoria del morbo di Crohn. 50
Mesalazine in the prevention of clinical and endoscopical postoperative recurrence of Crohn’s disease: a meta-analysis. 50
Could Infliximab Avoid Colectomy in Patients With Severe Ulcerative Colitis? A Multicentre Italian Experience. 50
Can Nrf2 modulate the development of intestinal fibrosis and cancer in inflammatory bowel disease? 50
What are the challenges in selecting pharmacotherapy for pregnant women with inflammatory bowel disease? 50
Natural history of recurrent lesions following intestinal resection for Crohn’s disease 48
Fattori di rischio per la recidiva post-operatoria nel morbo di Crohn. 48
Mesalazine vanishing time from rectal mucosa following its topical administration. 48
Two mesalazine regimens in the prevention of postoperative recurrence (POR) of Crohn's disease: A double blind randomised controlled trial by GISC with a meta-analysis of other studies. 48
Acute intestinal obstruction and NOD2/CARD15 mutations among italian Crohn's disease patients 48
Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases 48
Duodenal lymphocytosis in functional dyspepsia 47
Topical Aminosalicylates and Histologic Healing in Ulcerative Colitis 47
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 47
Sleep disorders related to nutrition and digestive diseases: A neglected clinical condition 47
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role? 47
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 47
Chronic Diarrhoea. In: Chronic Gastrointestinal Disorders, E.Corazziari Ed, Milano, Messaggi, 1999:295-302 46
Food Allergies and Ageing 46
Is mesalazine treatment effective in the prevention of diverticulitis? A review 46
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis? 46
Malattia di Crohn con recidive multiple. In: Malattie Infiammatorie Intestinali. Presentazione di casi clinici. A cura di M. Cottone, Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Milano, A. Tencati Ed., 1999: 171-180 45
Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) 45
Totale 6.436
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.370
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.370
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020869 0 4 92 7 12 176 170 77 151 42 14 124
2020/20211.113 36 134 3 168 146 25 150 17 137 28 232 37
2021/2022799 34 60 94 39 32 27 12 58 43 32 68 300
2022/20232.841 216 159 44 293 257 301 0 204 1.233 16 84 34
2023/2024990 98 28 29 91 47 167 30 285 4 39 51 121
2024/202597 69 28 0 0 0 0 0 0 0 0 0 0
Totale 8.266